The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics
In pre-klinisch onderzoek dient het als gedefinieerd hulpmiddel om oxidatieve-stress-mechanismen en redox-signalering te bestuderen
GLP-1 agonists significantly reduced kidney deterioration and failure, regardless of diabetes status The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes
61 One of the most well-known studies of TPE, the double-blind placebo-controlled AD management by albumin replacement (AMBAR) trial, hypothesized that withdrawing plasma might flush A plaque from the brain into the plasma where it could be removed, thereby reducing AD signs and symptoms
As IGF-1R mAbs are readily available for human use, these observations warrant further study into potentially harnessing these drugs to target at least some manifestations of aging
CagriSema versus tirzepatide in people with type 2 diabetes